Horizon Therapeutics USA, Inc.
H-1B Sponsorship & Salary Data — Government-Verified
$148,512Avg. Salary
20Filings
17+Job Titles
December 2025Last Filing
According to TheRealSalaries.com analysis of official US Department of Labor filings (October 2024 - December 2025), Horizon Therapeutics USA, Inc. pays a median H-1B salary of $135,850 — 12% above the national median of $121,514, ranking in the top 25% of 13,957 ranked H-1B sponsors. Based on 20 certified Labor Condition Applications.
Section 1
What does Horizon Therapeutics USA, Inc. pay?
Horizon Therapeutics USA, Inc.'s H-1B filings show an average salary of $148,512 based on 20 certified LCA applications. Salaries range from $90,904 to $230,000.
$148,512
Average
$135,850
Median
$90,904
Minimum
$230,000
Maximum
Recent H-1B Filings
| Job Title | Salary |
|---|---|
| Sr. Associate Value & Insights | $113,740 |
| Regulatory Affairs Senior Manager | $230,000 |
| Commercial Forecasting Senior Manager | $170,000 |
| Regulatory Affairs Senior Manager | $230,000 |
| Biostatistics Manager | $145,001 |
| Data Scientist | $105,800 |
| Sr Associate Finance | $90,904 |
| Sr Associate Commercial Analytics | $112,255 |
| Data Management Sr Mgr | $181,381 |
| Information Systems Director | $203,000 |
| Senior Associate, Commercial Analytics | $117,306 |
| Commercial Insights Manager | $135,850 |
| Commercial Insights Manager | $135,850 |
| Sr Manager, Patient & Access Analytics (Rare Disease) | $172,425 |
| Sr Analyst, Commercial Analytics (Rare Disease) | $105,000 |
| Senior Analyst, Commercial Analytics & Insights | $109,203 |
| Manager, Biostatistics (Rare Disease) | $151,525 |
| Commercial Analysis Manager | $125,000 |
| Biostatistics Senior Manager | $168,000 |
| Biostatistics Manager | $168,000 |
Section 2
States with Horizon Therapeutics USA, Inc. H-1B Filings
Similar Companies
Section 3
All salaries above must meet the Department of Labor's wage floor — see how the H-1B prevailing wage levels work, or browse all sponsor companies.
Source: US Department of Labor LCA Disclosure Data. Last updated: Q1 FY2025.